Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: J Clin Gastroenterol. 2019 Feb;53(2):e46–e53. doi: 10.1097/MCG.0000000000000946

Table 1.

Study population characteristics by levels of liver enzymes and Pediatric NAFLD Fibrosis Index

ALT* AST GGT PNFI



≤25 U/L
(N=1,146)
>25 U/L
(N=171)
<37 U/L
(N=1,266)
≥37 U/L
(N=51)
<17 U/L
(N=1,042)
≥17 U/L
(N=275)
<9
(N=1,149)
≥9
(N=168)



Weighted
Mean (SE)
or %
Weighted
Mean or %
(SE)
Weighted
Mean or %
(SE)
Weighted
Mean or %
(SE)
Weighted
Mean or %
(SE)
Weighted
Mean or %
(SE)
Weighted
Mean or %
(SE)
Weighted
Mean or %
(SE)



Age, years 12.2 (0.1) 11.9 (0.3) 12.2 (0.1) 11.5 (0.4) 12.0 (0.1) 13.0 (0.2) 12.2 (0.1) 12.2 (0.2)
Male 50.0% 62.0% 50.7% 72.7% 48.1% 64.6% 51.1% 54.7%
Household income
  ≤$20, 000 53.7% 46.4% 53.1% 41.9% 52.0% 55.4% 51.6% 61.9%
  $21,000–$40,000 31.3% 36.3% 31.4% 46.7% 32.8% 28.7% 33.5% 19.7%
  >$40,000 15.0% 17.3% 15.5% 11.5% 15.2% 15.9% 14.9% 18.3%
Parental education
  <High school 37.3% 42.1% 37.6% 46.5% 36.9% 41.7% 37.5% 41.3%
  High school 29.8% 28.9% 29.7% 27.2% 30.0% 28.2% 29.3% 32.4%
  >High school 32.9% 29.0% 32.7% 26.3% 33.0% 30.2% 33.2% 26.2%
Alcohol use in the past 30 days 5.3% 3.9% 5.1% 5.2% 4.6% 7.0% 4.7% 8.7%
Waist circumference ≥90th percentile 9.8% 31.0% 11.7% 35.2% 8.0% 30.0% 3.5% 82.8%
BMI category
  Under/Normal weight 58.0% 26.9% 55.0% 26.8% 60.3% 30.0% 60.9% 0.4%
  Overweight 20.4% 14.8% 20.1% 6.4% 20.2% 17.7% 22.0% 1.8%
  Obese 21.6% 58.3% 24.8% 66.8% 19.6% 52.3% 17.1% 97.8%
Moderate/vigorous activity, minutes per day 36.2 (1.1) 31.1 (2.2) 35.6 (1.0) 33.6 (3.8) 36.5 (1.1) 31.9 (1.8) 36.7 (1.0) 27.0 (2.3)
Pubertal 59.7% 45.0% 58.3% 45.1% 56.2% 64.3% 58.0% 56.9%
Systolic BP ≥90th percentile 4.1% 4.1% 4.0% 8.6% 3.8% 5.3% 4.2% 3.4%
Diastolic BP ≥90th percentile 2.5% 2.0% 2.3% 5.9% 2.1% 3.7% 2.4% 2.8%
Total cholesterol, mg/dL 153 (1.1) 159 (2.7) 154 (1.1) 155 (4.3) 153 (1.2) 158 (2.5) 153 (1.1) 166 (3.0)
LDL-c, mg/dL 86 (1.0) 90 (2.3) 87 (0.9) 88 (3.8) 86 (1.0) 91 (2.0) 85 (0.9) 97 (2.6)
HDL-c, mg/dL 53 (0.5) 49 (1.1) 52 (0.4) 47 (1.9) 53 (0.5) 48 (0.8) 53 (0.5) 42 (0.8)
Triglycerides, mg/dL 66 (49–91) 89 (59–126) 67 (50–93) 100 (74–116) 65 (48–89) 83 (57–129) 64 (47–86) 124 (90–171)
hs-CRP, mg/L 0.4 (0.2–1.0) 0.9 (0.3–2.5) 0.4 (0.2–1.1) 1.4 (0.6–2.9) 0.4 (0.2–0.9) 1.1 (0.4–2.5) 0.4 (0.2–0.9) 2.1 (1.0–4.1)
Adiponectin, ng/mL 8060 (162) 6640 (484) 7935 (160) 6283 (573) 8308 (184) 6215 (231) 8211 (163) 5281 (222)
PAI-1, ng/mL 1.8 (1.1–3.1) 3.7 (1.9–5.7) 1.9 (1.2–3.3) 4.2 (1.9–6.0) 1.8 (1.1–3.0) 3.1 (1.5–4.7) 1.7 (1.1–3.0) 3.9 (2.8–6.3)
e-selectin, ng/mL 47.7 (0.8) 65.2 (2.6) 49.2 (0.8) 70.0 (5.4) 48.4 (0.8) 55.8 (1.9) 48.1 (0.8) 64.2 (2.9)
Fasting glucose, mg/dL 91.7 (0.3) 91.8 (0.6) 91.6 (0.3) 93.6 (1.0) 91.7 (0.3) 91.9 (0.5) 91.6 (0.3) 92.8 (0.7)
Fasting glucose ≥100 mg/dL 10.5% 6.4% 9.9% 12.5% 10.0% 9.9% 9.3% 15.8%
HbA1c, % 5.2 (0.01) 5.3 (0.02) 5.2 (0.01) 5.3 (0.06) 5.2 (0.01) 5.3 (0.03) 5.2 (0.01) 5.3 (0.03)
HbA1c ≥5.7% 8.0% 6.8% 8.0% 4.2% 6.9% 11.5% 7.4% 11.0%
HOMA-IR ≥2.6 49.5% 74.0% 51.8% 75.7% 47.7% 71.8% 47.2% 95.0%
HOMA-IR 2.6 (1.7–3.9) 4.4 (2.5–6.8) 2.7 (1.7–4.1) 4.7 (2.6–7.4) 2.5 (1.7–3.8) 4.3 (2.3–6.7) 2.5 (1.7–3.7) 6.3 (4.6–8.6)

Bolded values indicate p<0.05 for comparison of characteristics in persons with normal versus elevated liver enzymes or PNFI. P-values were calculated using Wald tests.

*

ALT cut-points for boys were ≤25 U/L versus >25 U/L. For girls, cut-points were ≤22 U/L versus >22 U/L.

Weighted medians (25th–75th percentiles) are presented, since distributions of these variables were skewed.